Growth Metrics

Myriad Genetics (MYGN) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to $400000.0.

  • Myriad Genetics' Other Non Operating Income rose 15000.0% to $400000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $700000.0, marking a year-over-year increase of 60000.0%. This contributed to the annual value of $1.1 million for FY2024, which is 12500.0% up from last year.
  • As of Q3 2025, Myriad Genetics' Other Non Operating Income stood at $400000.0, which was up 15000.0% from -$100000.0 recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Other Non Operating Income registered a high of $120.6 million during Q3 2021, and its lowest value of -$2.4 million during Q2 2023.
  • Over the past 5 years, Myriad Genetics' median Other Non Operating Income value was $0.0 (recorded in 2021), while the average stood at $8.6 million.
  • Per our database at Business Quant, Myriad Genetics' Other Non Operating Income skyrocketed by 763750.0% in 2021 and then plummeted by 250000.0% in 2023.
  • Myriad Genetics' Other Non Operating Income (Quarter) stood at $120.6 million in 2021, then crashed by 99.59% to $500000.0 in 2022, then tumbled by 240.0% to -$700000.0 in 2023, then surged by 142.86% to $300000.0 in 2024, then surged by 33.33% to $400000.0 in 2025.
  • Its Other Non Operating Income was $400000.0 in Q3 2025, compared to -$100000.0 in Q2 2025 and $100000.0 in Q1 2025.